Study of polymorphisms in the IL17A and IL17RA genes and IL-17A, IL-33 and CCL2 production in infected pregnant women with Toxoplasma gondii from the State of Rio Grande do Norte, Brazil.
Toxoplasma gondii, Gene polymorphism, cytokines, IL17, Clinical Manifestations.
Toxoplasmosis is an infectious parasitic disease that triggers Toxoplasma gondii, which can cause tumors when immunocompromised and/or vertically infected, triggering encephalitis, chorioretinitis and neurological and psychiatric disorders. In the present study, we evaluated polymorphisms for IL-17A and IL-17RA genes, as well as IL-17A, IL-33 and CCL2 status of patients with clinical manifestations of toxoplasmosis in the state of Rio Grande do Norte. The non-polymorphic range of the SNP rs2275913, located in the promoter region of its IL17A gene, has shown that the G allele has a protective role in the population of pregnant women, but not in the population with ocular toxoplasmosis. What is polymorphism -809 A> G SNP rs4819554, located without gene by the coding of the IL-17A receptor, IL-17RA, results found in the population of pregnant women, the allele With protective effect of the G allele non-polymorphism IL17A -197 (Rs2275913), but in the population with ocular toxoplasmosis, the presence of two alleles related to increased IL-17A activity is associated with the manifestation of symptoms characteristic of this form of toxoplasmosis. When analyzing the cytokine/chemokine dosages IL-17A, IL-33, and CCL2, it was found that this contributed to the clinical picture of hypertension in women, but not to those who reported the occurrence of abortion. This work, therefore, presents a broader perspective of the immunomodulation promoted by T. gondii, in the population of Rio Grande do Norte.